差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

交易 Monopar Therapeutics Inc. - MNPR CFD

-
0%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 -
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024874%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.002651%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* N/A
開盤價* N/A
1 年變化* N/A
日範圍* N/A
52 周範圍 1.30-4.88
平均交易量(10 天) 102.83K
平均交易量(3 個月) 754.41K
市值 18.34M
市盈率 -100.00K
流通股 13.19M
收入 N/A
EPS -0.83
股息(收益率 %) N/A
貝塔 -100.00K
下一個財報發布日期 May 10, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開

Monopar Therapeutics Inc. Events

时间(协调世界时) (UTC) 国家 事件
Monday, April 3, 2023

时间(协调世界时) (UTC)

17:00

国家

US

事件

Monopar Therapeutics Inc at Jefferies Radiopharma Innovation Summit
Monopar Therapeutics Inc at Jefferies Radiopharma Innovation Summit

Forecast

-

Previous

-
查看所有活动
  • 年度
  • 每季度
2022 2021 2020 2019 2018
總收入 0 0 0 0 0
收入 0 0
總營業費用 10.5369 9.12725 6.50888 4.32376 3.33115
銷售/一般/行政費用,總計 2.94528 2.63404 2.44368 2.35524 1.55669
研究與開發 7.5916 6.49321 4.0652 1.96852 1.77445
營業收入 -10.5369 -9.12725 -6.50888 -4.32376 -3.33115
利息收入(費用),非經營淨值 0.02124 0.02402 0.0819 0.09889 0.10322
稅前淨收入 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
稅後淨收入 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
未計算非常項目前的淨收益 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
淨收入 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
普通股股東可獲收益 (不含非經常性項目) -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
普通股股東可獲收益 (含非經常性項目) -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
攤薄淨收入 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
攤薄後加權平均股 12.7182 12.4722 10.9583 10.421 10.421
扣除特別項目的每股攤薄盈利 -0.82682 -0.72988 -0.57533 -0.40542 -0.30975
Dividends per Share - Common Stock Primary Issue 0
每股正常攤薄盈利 -0.82682 -0.72988 -0.57533 -0.40542 -0.30975
其他,淨值 0 0.1224
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
總收入 0 0 0 0 0
總營業費用 2.909 2.40735 2.76335 2.45719 2.68112
銷售/一般/行政費用,總計 0.80874 0.67512 0.68488 0.77925 0.69844
研究與開發 2.10297 1.73223 2.07847 1.67793 1.98268
營業收入 -2.909 -2.40735 -2.76335 -2.45719 -2.68112
利息收入(費用),非經營淨值 0.01266 0.0077 0.00042 0.00046 0.00053
稅前淨收入 -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
稅後淨收入 -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
未計算非常項目前的淨收益 -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
淨收入 -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
普通股股東可獲收益 (不含非經常性項目) -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
普通股股東可獲收益 (含非經常性項目) -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
攤薄淨收入 -2.89634 -2.39965 -2.76293 -2.45672 -2.68059
攤薄後加權平均股 12.8795 12.7547 12.6324 12.6044 12.5919
扣除特別項目的每股攤薄盈利 -0.22488 -0.18814 -0.21872 -0.19491 -0.21288
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 -0.22488 -0.18814 -0.21872 -0.19491 -0.21288
Other Operating Expenses, Total -0.00271
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 20.5216 16.7998 13.2296 7.25222 9.13124
現金和短期投資 20.3039 16.7371 13.2139 6.89277 8.98189
現金等價物 20.3039 16.7371 13.2139 6.89277 8.98189
Other Current Assets, Total 0.21775 0.06269 0.01571 0.35945 0.14934
Total Assets 20.5216 16.8687 13.352 7.31796 9.93127
Other Long Term Assets, Total 0 0.06886 0.12238 0.06573 0.80003
Total Current Liabilities 1.58054 1.17667 0.72417 0.39955 0.31187
Payable/Accrued 1.58054 1.17667 0.72417 0.39955 0.31187
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.58054 1.17667 0.72417 0.39955 0.31187
Total Long Term Debt 0 0 0 0 0
Total Equity 18.9411 15.692 12.6279 6.9184 9.6194
Preferred Stock - Non Redeemable, Net
Common Stock 0.0126 0.01145 0.01059 0.00929 0.00929
Additional Paid-In Capital 60.22 47.8736 38.5088 28.5672 28.0379
Other Equity, Total -0.00316 -0.00787 -0.01097 -0.0024 -18.4278
Total Liabilities & Shareholders’ Equity 20.5216 16.8687 13.352 7.31796 9.93127
Total Common Shares Outstanding 12.5981 11.4535 10.6215 10.421 10.421
Retained Earnings (Accumulated Deficit) -41.2884 -32.1852 -25.8806 -21.6557
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 18.0127 20.5216 22.4484 24.3884 25.8377
現金和短期投資 17.819 20.3039 22.3416 24.2929 25.7231
現金等價物 17.819 20.3039 22.3416 24.2929 25.7231
Other Current Assets, Total 0.19364 0.21775 0.1068 0.09556 0.11457
Total Assets 18.0664 20.5216 22.5172 24.4573 25.9065
Other Long Term Assets, Total 0 0.06886 0.06886 0.06886
Total Current Liabilities 1.07412 1.58054 1.23994 1.10364 0.80627
Payable/Accrued 1.04815 1.58054 1.23994 1.10364 0.80627
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.09946 1.58054 1.23994 1.10364 0.80627
Total Long Term Debt 0 0 0 0 0
Total Equity 16.9669 18.9411 21.2773 23.3536 25.1003
Common Stock 0.01262 0.0126 0.01259 0.01258 0.01257
Additional Paid-In Capital 60.7031 60.22 59.8776 59.4955 59.162
Retained Earnings (Accumulated Deficit) -43.7451 -41.2884 -38.6078 -36.1493 -34.0692
Other Equity, Total -0.00374 -0.00316 -0.00515 -0.00516 -0.0051
Total Liabilities & Shareholders’ Equity 18.0664 20.5216 22.5172 24.4573 25.9065
Total Common Shares Outstanding 12.6206 12.5981 12.5906 12.5827 12.5699
Property/Plant/Equipment, Total - Net 0.05369
Accrued Expenses 0.02598
Other Liabilities, Total 0.02534
  • 年度
  • 每季度
2022 2021 2020 2019 2018
淨收入/起跑線 -10.5156 -9.10322 -6.30457 -4.22487 -3.22793
經營活動産生的現金 -7.22856 -7.3174 -4.66227 -3.01768 -2.68049
非現金物品 1.64126 1.46805 1.19849 1.01117 0.52933
營運資金的變化 1.64582 0.31777 0.44381 0.19602 0.01811
融資活動産生的現金 0.03287 10.8795 8.18212 9.34741 -0.20627
融資現金流項目 -0.07663 -0.06325 -0.11557 -0.98481 -0.20627
股票的發行(報廢),淨額 0.10951 10.9428 8.17529 10.3322 0
現金淨變化 -12.1177 3.56676 3.52318 6.32116 -2.88915
外彙效應 -0.00348 0.00462 0.00333 -0.00857 -0.0024
Cash Taxes Paid 0 -0.0111
債務的發行(退還),淨額 0.1224
投資活動産生的現金 -4.91851
其他投資現金流量項目,總計 -4.91851
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -10.5156 -7.6193 -5.21965 -2.45672 -9.10322
Cash From Operating Activities -7.22856 -5.92675 -3.77828 -2.4675 -7.3174
Non-Cash Items 1.64126 1.24785 0.85711 0.49981 1.46805
Changes in Working Capital 1.64582 0.4447 0.58427 -0.51059 0.31777
Cash From Financing Activities 0.03287 -0.10586 -0.08213 -0.01667 10.8795
Financing Cash Flow Items -0.07663 -0.10603 -0.08217 -0.01667 -0.06325
Issuance (Retirement) of Stock, Net 0.10951 0.00017 0.00004 0 10.9428
Foreign Exchange Effects -0.00348 0.04521 0.0201 -0.00066 0.00462
Net Change in Cash -12.1177 -5.98741 -3.8403 -2.48483 3.56676
Issuance (Retirement) of Debt, Net
Cash From Investing Activities -4.91851
Other Investing Cash Flow Items, Total -4.91851
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Tacticgem LLC Corporation 31.1621 4111273 0 2022-04-15 LOW
Gem Pharmaceuticals LLC Corporation 23.1589 3055394 0 2022-04-15 LOW
Hendricks (Diane) Individual Investor 3.553 468750 0 2022-04-15 LOW
Brown Michael J Individual Investor 1.711 225730 2859 2022-12-31 LOW
Tactic Pharma LLC Corporation 1.2633 166667 0 2022-04-15 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.7578 99976 97 2022-12-31 LOW
Robinson (Chandler D) Individual Investor 0.5816 76730 4396 2023-01-01 LOW
Starr (Christopher M) Individual Investor 0.4937 65130 2859 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3175 41892 2721 2022-12-31 LOW
Cittadine (Andrew) Individual Investor 0.2038 26894 2656 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1735 22884 -293 2022-12-31 LOW
Mazar (Andrew Paul) Individual Investor 0.1677 22125 0 2022-04-15 LOW
Klausner (Arthur J) Individual Investor 0.1571 20730 2859 2022-12-31 LOW
Tsuchimoto (Kim R) Individual Investor 0.1403 18507 728 2023-01-01 MED
Anderson (Raymond William) Individual Investor 0.1268 16730 2859 2022-12-31 MED
Northern Trust Global Investments Investment Advisor 0.1 13197 0 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.0303 4000 0 2022-12-31 LOW
UBS Financial Services, Inc. Investment Advisor 0.0239 3154 -2245 2022-12-31 LOW
Tower Research Capital LLC Hedge Fund 0.0215 2831 -300 2022-12-31 HIGH
Paragon Wealth Strategies, LLC Investment Advisor 0.0004 58 0 2022-12-31 HIGH

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Biotechnology & Medical Research (NEC)

1000 Skokie Blvd Ste 350
WILMETTE
ILLINOIS 60091-1146
US

收入報表

  • Annual
  • Quarterly

人們也觀看

BTC/USD

28,516.15 Price
+0.310% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
多頭倉位隔夜費用 -0.0156%
空頭倉位隔夜費用 -0.0063%
隔夜費時間 21:00 (UTC)
價差 0.03

US100

13,186.80 Price
+1.680% 1D Chg, %
多頭倉位隔夜費用 -0.0249%
空頭倉位隔夜費用 0.0027%
隔夜費時間 21:00 (UTC)
價差 3.0

Gold

1,969.66 Price
-0.550% 1D Chg, %
多頭倉位隔夜費用 -0.0185%
空頭倉位隔夜費用 0.0102%
隔夜費時間 21:00 (UTC)
價差 0.30

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易